LITFULO
Live / Registered — Registered (as of 12 Dec 2023)
What this means for you
Registered since 12 Dec 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90723569
- Registration number
- 7243324
- Mark type
- Stylized text
- Filed
- 20 May 2021
- Published for opposition
- 01 Mar 2022
- Registered
- 12 Dec 2023
- Attorney of record
- Heather A. McDonald
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of alopecia areata
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 12 Dec 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Dec 2023 — REGISTERED-PRINCIPAL REGISTER
- 08 Nov 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Nov 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Oct 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Oct 2023 — USE AMENDMENT FILED
- 27 Oct 2023 — SOU EXTENSION 3 GRANTED
- 18 Oct 2023 — SOU EXTENSION 3 FILED
- 27 Oct 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Oct 2023 — SOU TEAS EXTENSION RECEIVED
- 18 Oct 2023 — TEAS STATEMENT OF USE RECEIVED
- 19 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Apr 2023 — SOU EXTENSION 2 GRANTED
- 17 Apr 2023 — SOU EXTENSION 2 FILED